ReviewMolecular biology reports2025
Quercetin and hematological cancers: where are we and where are we going?
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is recognized as a significant health challenge in the present era. Hematological cancers, including malignant lymphoma, leukemia, and multiple myeloma, are a group of malignancies associated with high morbidity and mortality. Despite efforts by researchers to improve medical knowledge, there still remains a need for efficient and safe therapeutic strategies. Plant-derived natural products have emerged as potential preventive and therapeutic options against various diseases including cancer. Quercetin, a bioactive flavonoid found in fruits and vegetables, possesses anti-neoplastic, anti-inflammatory, anti-oxidative, anti-bacterial, anti-viral, and anti-fungal properties. There is increasing evidence suggesting the therapeutic potential of quercetin against hematological neoplasms through different molecular and cellular mechanisms, such as influencing apoptosis and autophagy, angiogenesis, inflammation, and antioxidant system capacity. This review aims to explore the therapeutic effects and underlying mechanisms of action of quercetin against these cancers.
Indexed as
Identifiers
40982155What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.